These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 25595884)
1. Hepatic p38α regulates gluconeogenesis by suppressing AMPK. Jing Y; Liu W; Cao H; Zhang D; Yao X; Zhang S; Xia H; Li D; Wang YC; Yan J; Hui L; Ying H J Hepatol; 2015 Jun; 62(6):1319-27. PubMed ID: 25595884 [TBL] [Abstract][Full Text] [Related]
2. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice. Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506 [TBL] [Abstract][Full Text] [Related]
3. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK). Sun WX; Lou K; Chen LJ; Liu SD; Pang SG J Endocrinol Invest; 2021 Aug; 44(8):1753-1765. PubMed ID: 33423221 [TBL] [Abstract][Full Text] [Related]
4. Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice. Qi X; Guo Y; Song Y; Yu C; Zhao L; Fang L; Kong D; Zhao J; Gao L Diabetologia; 2018 May; 61(5):1180-1192. PubMed ID: 29442133 [TBL] [Abstract][Full Text] [Related]
5. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice. Jeong KJ; Kim DY; Quan HY; Jo HK; Kim GW; Chung SH Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657 [TBL] [Abstract][Full Text] [Related]
6. Involvement of AMPK activation in the inhibition of hepatic gluconeogenesis by Ficus carica leaf extract in diabetic mice and HepG2 cells. Zhang Y; Chen J; Zeng Y; Huang D; Xu Q Biomed Pharmacother; 2019 Jan; 109():188-194. PubMed ID: 30396076 [TBL] [Abstract][Full Text] [Related]
7. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase. Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922 [TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo. Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176 [TBL] [Abstract][Full Text] [Related]
9. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis. Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427 [TBL] [Abstract][Full Text] [Related]
10. Role of hepatic AMPK activation in glucose metabolism and dexamethasone-induced regulation of AMPK expression. Viana AY; Sakoda H; Anai M; Fujishiro M; Ono H; Kushiyama A; Fukushima Y; Sato Y; Oshida Y; Uchijima Y; Kurihara H; Asano T Diabetes Res Clin Pract; 2006 Aug; 73(2):135-42. PubMed ID: 16503364 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis. Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223 [TBL] [Abstract][Full Text] [Related]
12. Effects of Bofu-Tsusho-San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice. Lin CH; Kuo YH; Shih CC Int J Mol Sci; 2014 Nov; 15(11):20022-44. PubMed ID: 25375187 [TBL] [Abstract][Full Text] [Related]
14. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097 [TBL] [Abstract][Full Text] [Related]
15. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Koo SH; Flechner L; Qi L; Zhang X; Screaton RA; Jeffries S; Hedrick S; Xu W; Boussouar F; Brindle P; Takemori H; Montminy M Nature; 2005 Oct; 437(7062):1109-11. PubMed ID: 16148943 [TBL] [Abstract][Full Text] [Related]
19. Decreased fasting blood glucose is associated with impaired hepatic glucose production in thyroid-stimulating hormone receptor knockout mice. Wang T; Xu J; Bo T; Zhou X; Jiang X; Gao L; Zhao J Endocr J; 2013; 60(8):941-50. PubMed ID: 23665701 [TBL] [Abstract][Full Text] [Related]
20. The protease SENP2 controls hepatic gluconeogenesis by regulating the SUMOylation of the fuel sensor AMPKα. Dou X; Zhou WY; Ding M; Ma YJ; Yang QQ; Qian SW; Tang Y; Tang QQ; Liu Y J Biol Chem; 2022 Feb; 298(2):101544. PubMed ID: 34971706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]